
The pharmaceutical industry has spent the last two years debating whether direct-to-patient pharma business models are real. That debate is over.
Sierra Benbrook is a Senior Director with Alvarez & Marsal's Life Sciences Group in Dallas, Texas. She works with Pharma, distributors, PBMs, and pharmacies to design the next generation of business models and customer strategies at a time of rapid disruption and convergence across healthcare.
Her knowledge base spans corporate finance, M&A, growth-led transformations, go-to-market strategies, and operating model design, with a specialization in patient services, market access, specialty pharmacy, and channel and trade strategies.